HITAP was invited to attend the “Strengthening Health and Disease Modelling for Public Health Decision Making” organised by the Bill and Melinda Gates Foundation (BMGF) and Wellcome on June 7–8, 2023 in Kigali, Rwanda. It brought together 110 virtual and on-site attendees, with 76 on-site modellers,

Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio

Dr. Arpaporn Sutipatanasomboon is experienced in cell biology and molecular genetics research and is a registered patent agent with the Thailand Department of Intellectual Property. Her passion is to integrate early health technology assessment and intellectual property management to support decision makers, innovators and promote access to innovat

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

Sarin KC is Head of the Environmental Economics Unit at HITAP, Ministry of Public Health, Thailand. Previously, he worked as a research analyst at the London School of Economics and Political Science (LSE) and the Ministry of Health and Population in Nepal.As a health economist, he has helped institutionalise Health Technology Assessment (HTA) in c

Apirujee Punjataewakupt, PhD, earned her doctoral degree in pharmaceutical sciences from Chulalongkorn University. She has diverse experience in both the pharmaceutical industry and health-related research. She is currently serving as a research assistant at the Health Intervention and Technology Assessment Program (HITAP).Her expertise includes ph

Siobhan has spent over 10 years working in public health at the national, regional, and global level, with experience across health technology assessment, market shaping, vaccine implementation, and capacity building in Asia, Africa, and the Americas. She has led studies employing a variety of methodologies, including system dynamics, qualitative c

Panupong Chaowanasawat is an Associate at the Health Intervention and Technology Assessment Program (HITAP). He holds a Bachelor of Science in Public Health (Honors) with a minor in Global Health and Social Medicine from Wayne State University, USA. His academic and professional background reflects a strong commitment to public health research and